January 30, 2018 / 12:04 PM / 4 months ago

BRIEF-Revive Therapeutics Advances Research Program Of Cannabinoid-Based Therapies Targeting Liver Diseases

Jan 30 (Reuters) - Revive Therapeutics Ltd:

* REVIVE THERAPEUTICS ADVANCES RESEARCH PROGRAM OF CANNABINOID-BASED THERAPIES TARGETING LIVER DISEASES

* REVIVE THERAPEUTICS LTD - RESEARCH WILL BE OVERSEEN BY SANYAL BIOTECHNOLOGY LLC COMPANY’S STRATEGIC RESEARCH PARTNER FOR LIVER DISEASES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below